Antimicrobial Resistance Surveillance Market Analysis

Antimicrobial Resistance Surveillance Market Analysis

Based on solution, the market is divided into diagnostic kits, diagnostic systems, diagnostic software, and services. The diagnostic kits segment is poised to surpass USD 4.2 billion by the end of 2032.
 

• Diagnostic kits provide rapid and accurate identification of pathogens and their antimicrobial resistance profiles. This is crucial for timely and targeted treatment, allowing healthcare providers to administer the most effective antibiotics promptly.
   
• Further, these kits are often user-friendly and require minimal training to operate. This makes them accessible in various healthcare settings, including resource-limited areas where sophisticated laboratory equipment may not be available.
   
• Additionally, many diagnostic kits are designed for point-of-care testing, and can be used directly at the patient's bedside or in clinics. Thus, due to the several advantages they are expected to boost the segmental growth.
   

Based on application, the antimicrobial resistance surveillance market is classified into public health surveillance, laboratory surveillance, clinical diagnostics, and other applications. The clinical diagnostics segment held over USD 2.4 billion revenue in 2023.
 

• Clinical diagnostics are directly tied to patient care. With the rise of antimicrobial resistance, it has become crucial to identify resistant pathogens early. Consequently, it can quickly detect the presence of resistant strains and help guide physicians in prescribing appropriate antimicrobial therapy, reducing the risk of treatment failure.
   
• Furthermore, these diagnostic techniques include various tests, such as culture-based methods, molecular assays, and susceptibility testing, which enable the identification of specific pathogens and their resistance patterns to antimicrobial agents.
   
• Moreover, clinical diagnostics are essential for effective surveillance, as it support the efforts to combat antimicrobial resistance, and preserve the efficacy of antimicrobial agents for patient care, thereby escalating the segmental growth.
   

Based on end-use, the antimicrobial resistance surveillance market is segmented into hospitals, clinics, research & academic institutes, and other end-users. The hospitals segment accounted for 45.7% of the market share in 2023.
 

• Hospitals play a crucial role in antimicrobial surveillance as they serve as key sites for monitoring and managing antimicrobial resistance within healthcare settings.
   
• Furthermore, hospitals track changes in resistance patterns over time, allowing for the early detection of emerging threats and the identification of high-risk areas or patient populations.
   
• Moreover, by guiding treatment decisions, implementing stewardship programs, and enhancing infection control measures, hospitals contribute significantly to efforts aimed at combating antimicrobial resistance and safeguarding patient care, and thus, fostering the growth of the market.
   

North America antimicrobial resistance surveillance market size dominated around USD 2.4 billion 2023.
 

• The region is boasted with a sophisticated healthcare infrastructure, significant technological advancements, stringent regulations, and rising incidence of antimicrobial resistance.
   
• For instance, according to the Centers for Disease Control and Prevention (CDC), in 2019, over 2.8 million antimicrobial-resistant infections were reported in the U.S., resulting in more than 35,000 deaths.
   
• Furthermore, there is high awareness among healthcare professionals, and policymakers about the threats posed by antimicrobial resistance. This awareness drives the adoption of surveillance practices to monitor resistance patterns and guide appropriate antimicrobial use.